JP2022541925A5 - - Google Patents

Info

Publication number
JP2022541925A5
JP2022541925A5 JP2022504225A JP2022504225A JP2022541925A5 JP 2022541925 A5 JP2022541925 A5 JP 2022541925A5 JP 2022504225 A JP2022504225 A JP 2022504225A JP 2022504225 A JP2022504225 A JP 2022504225A JP 2022541925 A5 JP2022541925 A5 JP 2022541925A5
Authority
JP
Japan
Prior art keywords
subject
cells
jcv
specific
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022504225A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541925A (ja
JP7844327B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000606 external-priority patent/WO2021014213A1/en
Publication of JP2022541925A publication Critical patent/JP2022541925A/ja
Publication of JP2022541925A5 publication Critical patent/JP2022541925A5/ja
Priority to JP2025117147A priority Critical patent/JP2025160241A/ja
Application granted granted Critical
Publication of JP7844327B2 publication Critical patent/JP7844327B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504225A 2019-07-24 2020-07-23 ポリオーマウイルスのための免疫療法 Active JP7844327B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025117147A JP2025160241A (ja) 2019-07-24 2025-07-11 ポリオーマウイルスのための免疫療法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962878105P 2019-07-24 2019-07-24
US62/878,105 2019-07-24
PCT/IB2020/000606 WO2021014213A1 (en) 2019-07-24 2020-07-23 Immunotherapy for polyomaviruses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025117147A Division JP2025160241A (ja) 2019-07-24 2025-07-11 ポリオーマウイルスのための免疫療法

Publications (3)

Publication Number Publication Date
JP2022541925A JP2022541925A (ja) 2022-09-28
JP2022541925A5 true JP2022541925A5 (https=) 2023-08-01
JP7844327B2 JP7844327B2 (ja) 2026-04-13

Family

ID=74193506

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022504225A Active JP7844327B2 (ja) 2019-07-24 2020-07-23 ポリオーマウイルスのための免疫療法
JP2025117147A Pending JP2025160241A (ja) 2019-07-24 2025-07-11 ポリオーマウイルスのための免疫療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025117147A Pending JP2025160241A (ja) 2019-07-24 2025-07-11 ポリオーマウイルスのための免疫療法

Country Status (10)

Country Link
US (1) US20230192774A1 (https=)
EP (1) EP4004019A4 (https=)
JP (2) JP7844327B2 (https=)
KR (1) KR20220038457A (https=)
CN (1) CN114341164A (https=)
AU (1) AU2020317863A1 (https=)
BR (1) BR112022001199A2 (https=)
CA (1) CA3148391A1 (https=)
MX (1) MX2022001007A (https=)
WO (1) WO2021014213A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4347794A1 (en) * 2021-06-02 2024-04-10 Danmarks Tekniske Universitet Person-tailored t cell composition targeting merkel cell carcinoma
CN116621965A (zh) * 2022-05-06 2023-08-22 珠海丽凡达生物技术有限公司 治疗性核酸分子、混合物、药物及在治疗实体瘤中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008116468A2 (en) * 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP2791162A2 (en) * 2011-12-12 2014-10-22 Janssen Diagnostics BVBA Polyomavirus peptide sequences
WO2016073595A1 (en) * 2014-11-05 2016-05-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services T cells and dendritic cells for polyomavirus therapy
WO2017060283A1 (en) * 2015-10-06 2017-04-13 Universität Basel Specific immunodominant peptide epitopes for polyomavirus vaccine
CN110234358A (zh) * 2016-07-18 2019-09-13 昆士兰医学研究所理事会 多病毒特异性的t细胞免疫疗法
MX2019002566A (es) * 2016-09-09 2019-12-05 Atara Biotherapeutics Inc Inmunoterapia para poliomavirus.

Similar Documents

Publication Publication Date Title
US12458698B2 (en) Expansion of γδ T cells, compositions, and methods of use thereof
JP6081483B2 (ja) Ｔ細胞を増殖させるプロセス
JP2023065668A (ja) 養子細胞療法のための改良型細胞培養方法
Gao et al. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells
CN120733046A (zh) 用于治疗胰腺癌的药物组合物
CN107002039A (zh) 使用t细胞用于培养自然杀伤细胞的方法
Yan et al. The influence of microenvironment on survival of intraportal transplanted islets
US20100150886A1 (en) Method of Producing Lymphocytes
EP4426350A2 (en) Treatment of cancer with nk cells and multispecific engagers
JP2022541925A5 (https=)
WO2001038494A1 (en) Method of proliferating natural killer cells
US20170296584A1 (en) Methods for expanding t cell populations
CN110042080A (zh) 原发性肝癌肿瘤浸润淋巴细胞的分离、培养及体外扩增方法
WO2003070921A1 (fr) PROCÉDÉS DE PRODUCTION DE LYMPHOCYTES ϜδT
Chao et al. A novel human stem cell coculture system that maintains the survival and function of culture islet-like cell clusters
JP2023509388A5 (https=)
CN112266413A (zh) 扩增nk细胞并增强其杀伤活性的因子、饲养细胞系及方法
ES2383418T3 (es) Agente celular antiangiogénico para la terapia del cáncer.
CN120078889A (zh) 用于治疗胰腺癌的药物组合物
CN118516306A (zh) Nk细胞的制备方法及其在制备肿瘤免疫治疗药物中的用途
CN106880833B (zh) 抗原肽racgap1-1和racgap1-2在制备治疗肝癌药物中的应用
CN110628717B (zh) 一种浸润性t细胞的培养方法
Lugli et al. Harnessing stem cell-like memory T cells for adoptive cell transfer therapy of cancer
Rosenthal et al. Differential Responsiveness to IL-2, IL-7, and IL-15 Common Receptor γ Chain Cytokines by Antigen-specific Peripheral Blood Naive or Memory Cytotoxic CD8+ T Cells from Healthy Donors and Melanoma Patients
BR122025001918A2 (pt) Métodos de expansão de células t gama delta, composições, seu uso e uso de células t gama delta expandidas